Used in the synthesis of angiotensin II receptor antagonists, particularly in the development of sartan-class antihypertensive drugs. The compound acts as a key intermediate due to its functionalized pyrimidine core and tetrazole moiety, both of which are critical for binding to the angiotensin II receptor. Its structure allows for further chemical modifications to enhance pharmacokinetic properties such as bioavailability and metabolic stability. Commonly employed in pharmaceutical research for optimizing drug candidates targeting hypertension and related cardiovascular conditions.